Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey

Showing results (121-130 of 651) with videos related to

Pageof 66
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 26, 2008
Decline in native kidney function in liver transplant recipients is not associated with BK virus infectionMuna Salama, Neil Boudville, David Speers, et al.
Frontiers in Cellular and Infection Microbiology|November 26, 2020
Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular VesiclesHong Kiat Lim, Gary P Jeffrey, Grant A Ramm, et al.
Nature Reviews. Drug Discovery|September 2, 2014
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disordersP Jeffrey Conn, Craig W Lindsley, Jens Meiler, et al.
ACS Chemical Neuroscience|April 2, 2019
Shared Behavioral and Neurocircuitry Disruptions in Drug Addiction, Obesity, and Binge Eating Disorder: Focus on Group I mGluRs in the Mesolimbic Dopamine PathwaySamantha E Yohn, Jordan Galbraith, Erin S Calipari, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2005
A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activityRuggero Galici, Nicholas G Echemendia, Alice L Rodriguez, et al.
Inorganic Chemistry|January 30, 2008
Crown ether inclusion complexes of the early actinide elements, [AnO2(18-crown-6)]n+, An = U, Np, Pu and n = 1, 2: a relativistic density functional studyGrigory A Shamov, Georg Schreckenbach, Richard L Martin, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2008
Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffoldSameer Sharma, Alice L Rodriguez, P Jeffrey Conn, et al.
Gut|April 1, 1991
Histological and immunohistochemical study of the gall bladder lesion in primary sclerosing cholangitisG P Jeffrey, W D Reed, S Carrello, et al.
Neuroscience Letters|September 28, 2011
Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulataKari A Johnson, Colleen M Niswender, P Jeffrey Conn, et al.
Expert Review of Gastroenterology & Hepatology|April 2, 2015
The evolving epidemiology of hepatocellular carcinoma: a global perspectiveMichael C Wallace, David Preen, Gary P Jeffrey, et al.
Pageof 66

Showing results (121-130 of 651) with videos related to

Sort By:
Pageof 66
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 26, 2008
Decline in native kidney function in liver transplant recipients is not associated with BK virus infectionMuna Salama, Neil Boudville, David Speers, et al.
Frontiers in Cellular and Infection Microbiology|November 26, 2020
Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular VesiclesHong Kiat Lim, Gary P Jeffrey, Grant A Ramm, et al.
Nature Reviews. Drug Discovery|September 2, 2014
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disordersP Jeffrey Conn, Craig W Lindsley, Jens Meiler, et al.
ACS Chemical Neuroscience|April 2, 2019
Shared Behavioral and Neurocircuitry Disruptions in Drug Addiction, Obesity, and Binge Eating Disorder: Focus on Group I mGluRs in the Mesolimbic Dopamine PathwaySamantha E Yohn, Jordan Galbraith, Erin S Calipari, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2005
A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activityRuggero Galici, Nicholas G Echemendia, Alice L Rodriguez, et al.
Inorganic Chemistry|January 30, 2008
Crown ether inclusion complexes of the early actinide elements, [AnO2(18-crown-6)]n+, An = U, Np, Pu and n = 1, 2: a relativistic density functional studyGrigory A Shamov, Georg Schreckenbach, Richard L Martin, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2008
Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffoldSameer Sharma, Alice L Rodriguez, P Jeffrey Conn, et al.
Gut|April 1, 1991
Histological and immunohistochemical study of the gall bladder lesion in primary sclerosing cholangitisG P Jeffrey, W D Reed, S Carrello, et al.
Neuroscience Letters|September 28, 2011
Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulataKari A Johnson, Colleen M Niswender, P Jeffrey Conn, et al.
Expert Review of Gastroenterology & Hepatology|April 2, 2015
The evolving epidemiology of hepatocellular carcinoma: a global perspectiveMichael C Wallace, David Preen, Gary P Jeffrey, et al.
Pageof 66